EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours, medicated transdermal patch 3 patches in individual sachets
Active ingredients: Norelgestromin, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Medicated transdermal patch3 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EVRA 203 microgrammes/24 heures + 33,9 microgrammes/24 heures, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 3 sachet(s) polyéthylène basse densité (PEBD) aluminium papier de 1 dispositif(s)
- Marketing authorisation holder
- GEDEON RICHTER ( HONGRIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Dec 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69729088CIP73605146CIP133400936051461Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLdispositif | 600 microgrammes · un dispositif | SA |
| NORELGESTROMINEdispositif | 6 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.